BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CCND3, P30281, 896, ENSG00000112576 AND Diagnosis
30 results:

  • 1. A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse.
    Yan X; Chen B; Jing H; Yang Z; Zhang T; Lin Y; Shi J
    J Hematop; 2023 Dec; 16(4):235-240. PubMed ID: 38175437
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Mutational Spectrum and Prognosis Analysis of Young Patients with Diffuse Large B-Cell lymphoma Based on Next-Generation Sequencing].
    Lyu LY; Nie YL; Renaguli A; Qi XL; Muhebaier A; Zhai SS; An L; Mao M; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):403-410. PubMed ID: 37096512
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.
    Salmerón-Villalobos J; Castrejón-de-Anta N; Guerra-García P; Ramis-Zaldivar JE; López-Guerra M; Mato S; Colomer D; Diaz-Crespo F; Menarguez J; Garrido-Pontnou M; Andrés M; García-Fernández E; Llavador M; Frigola G; García N; González-Farré B; Martín-Guerrero I; Garrido-Colino C; Astigarraga I; Fernández A; Verdú-Amorós J; González-Muñíz S; González B; Celis V; Campo E; Balagué O; Salaverria I
    Blood; 2023 Aug; 142(5):434-445. PubMed ID: 37053555
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinical features and prognosis of eight patients with splenic diffuse red pulp small B-cell lymphoma].
    Zhang XL; Luo J; Zhang JJ; Chen L; Shen Y; Yi HM; Fan LQ; Mi JQ
    Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1028-1033. PubMed ID: 36709109
    [No Abstract]    [Full Text] [Related]  

  • 5. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
    Parry EM; Leshchiner I; Guièze R; Johnson C; Tausch E; Parikh SA; Lemvigh C; Broséus J; Hergalant S; Messer C; Utro F; Levovitz C; Rhrissorrakrai K; Li L; Rosebrock D; Yin S; Deng S; Slowik K; Jacobs R; Huang T; Li S; Fell G; Redd R; Lin Z; Knisbacher BA; Livitz D; Schneider C; Ruthen N; Elagina L; Taylor-Weiner A; Persaud B; Martinez A; Fernandes SM; Purroy N; Anandappa AJ; Ma J; Hess J; Rassenti LZ; Kipps TJ; Jain N; Wierda W; Cymbalista F; Feugier P; Kay NE; Livak KJ; Danysh BP; Stewart C; Neuberg D; Davids MS; Brown JR; Parida L; Stilgenbauer S; Getz G; Wu CJ
    Nat Med; 2023 Jan; 29(1):158-169. PubMed ID: 36624313
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Losing CD45 and various B-cell markers in a case of MYC-driven pediatric high-grade B-cell lymphoma, not otherwise specified that transformed from Burkitt's lymphoma during rituximab-containing treatments: a case report.
    Xue X; Fu L; Qiu T; Cao Z; Wang X; Rao W; Luo Y; He L; Feng X
    Virchows Arch; 2023 Jul; 483(1):111-116. PubMed ID: 36383247
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinicopathological and molecular genetic features of cyclin D1-negative mantle cell lymphoma].
    Wang GN; Zhang L; Li CF; Zhao WG; Zhang DD; Zhang YP; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):296-300. PubMed ID: 35359039
    [No Abstract]    [Full Text] [Related]  

  • 9. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
    Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The pathologic diagnosis of mantle cell lymphoma.
    Li S; Xu J; You MJ
    Histol Histopathol; 2021 Oct; 36(10):1037-1051. PubMed ID: 34114641
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary diffuse large B-cell lymphoma of the major salivary glands: Increasing incidence and survival.
    Gupta A; Lee JA; Nguyen SA; Lentsch EJ
    Am J Otolaryngol; 2021; 42(3):102938. PubMed ID: 33524741
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence.
    Magnes T; Wagner S; Thorner AR; Neureiter D; Klieser E; Rinnerthaler G; Weiss L; Huemer F; Zaborsky N; Steiner M; Weis S; Greil R; Egle A; Melchardt T
    ESMO Open; 2021 Feb; 6(1):100012. PubMed ID: 33399078
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Non-Classic Signs of Sézary Syndrome: A Review.
    Morris L; Tran J; Duvic M
    Am J Clin Dermatol; 2020 Jun; 21(3):383-391. PubMed ID: 31953789
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.
    Chuang WY; Chang ST; Yuan CT; Chang GJ; Chang H; Yeh CJ; Ueng SH; Kao HW; Wang TH; Wan YL; Shih LY; Chuang SS; Hsueh C
    Am J Surg Pathol; 2020 Feb; 44(2):232-240. PubMed ID: 31688139
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP.
    Kadota T; Seo S; Fuse H; Ishii G; Itoh K; Yano T; Kaneko K; Tsukasaki K
    Cancer Med; 2019 Mar; 8(3):982-989. PubMed ID: 30730104
    [TBL] [Abstract] [Full Text] [Related]  

  • 16.
    Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
    Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.
    Kang D; Park JE; Kim YH; Kim JH; Oh JY; Kim J; Kim Y; Kim ST; Kim HS
    Neuro Oncol; 2018 Aug; 20(9):1251-1261. PubMed ID: 29438500
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples.
    Wever CM; Geoffrion D; Grande BM; Yu S; Alcaide M; Lemaire M; Riazalhosseini Y; Hébert J; Gavino C; Vinh DC; Petrogiannis-Haliotis T; Dmitrienko S; Mann KK; Morin RD; Johnson NA
    Leuk Lymphoma; 2018 Sep; 59(9):2159-2174. PubMed ID: 29295643
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Weight change trends and overall survival in United States veterans with follicular lymphoma treated with chemotherapy.
    Xiao DY; Luo S; O'Brian K; Liu W; Carson KR
    Leuk Lymphoma; 2017 Apr; 58(4):851-858. PubMed ID: 27669828
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients.
    Geyer JT; Subramaniyam S; Jiang Y; Elemento O; Ferry JA; de Leval L; Nakashima MO; Liu YC; Martin P; Mathew S; Orazi A; Tam W
    Hum Pathol; 2015 Feb; 46(2):260-71. PubMed ID: 25529125
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.